Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2031250413) titled 'A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumors' on Oct. 6.
Study Type: Interventional
Study Design:
single arm study, open(masking not used), active control, single assignment, treatment purpose
Primary Sponsor: Hreiki Joseph
Condition:
Advanced Solid Tumors
Intervention:
Single arm, BMS-986504 Specified dose on specified days
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 22/10/2025
Target Sample Size: 12
Countries of Recruitment:
China
Japan
To know more, visit https://jrct.mhlw.go.jp/latest-detail/jRCT20...